U.S., Dec. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07309848) titled 'Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs' on Sept. 22.
Brief Summary: This study looks at patients with hip fractures who are taking direct oral anticoagulants (DOACs), a type of blood thinner. In many hospitals, surgery for these patients is delayed because of concerns about bleeding, but waiting longer can also increase risks such as complications and longer hospital stays. The purpose of this study is to find out whether operating within 24 hours is as safe as delaying surgery beyond 24 hours. Specifically, the investigators want to know if early surgery does not lead to a higher need for blood ...